Patent Assignment
Reel/Frame 066214/0216
Assignment of Assignor's Interest
Recorded: 2024-01-23
Pages: 7
Assignee
ALNYLAM PHARMACEUTICALS, INC.
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MASSACHUSETTS, 02142-1110
Covered Property
(1)
Metabolic Disorder-Associated Target Gene Irna Compositions and Methods of Use Thereof
Application:
18/403,912 →
Publication:
US 2024/0309370
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.